-
Subject Areas on Research
-
64-Section multi-detector row CT in the preoperative diagnosis of peritoneal carcinomatosis: correlation with histopathological findings.
-
A phase II evaluation of AMG 102 (rilotumumab) in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal carcinoma: a Gynecologic Oncology Group study.
-
A phase II evaluation of elesclomol sodium and weekly paclitaxel in the treatment of recurrent or persistent platinum-resistant ovarian, fallopian tube or primary peritoneal cancer: An NRG oncology/gynecologic oncology group study.
-
A phase II study of sorafenib in malignant mesothelioma: results of Cancer and Leukemia Group B 30307.
-
A phase II trial of docetaxel and bevacizumab in recurrent ovarian cancer within 12 months of prior platinum-based chemotherapy.
-
A phase II trial of oxaliplatin, docetaxel, and bevacizumab as first-line therapy of advanced cancer of the ovary, peritoneum, and fallopian tube.
-
A phase II trial of paclitaxel poliglumex in recurrent or persistent ovarian or primary peritoneal cancer (EOC): a Gynecologic Oncology Group Study.
-
A randomized phase II evaluation of weekly gemcitabine plus pazopanib versus weekly gemcitabine alone in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal carcinoma.
-
A unique case of rhabdoid tumor presenting as hemoperitoneum in an infant.
-
Abdominal leiomyosarcoma: aggressive management.
-
Abdominal pain and a pelvic mass.
-
Adenocarcinoma Ex-Goblet Cell: a Retrospective Experience.
-
Asbestos Fiber Concentrations in the Lungs of Brake Repair Workers: An Updated Analysis Using Several Regression Methods to Handle Nondetectable Measurements.
-
Asbestos content of lung tissue in patients with malignant peritoneal mesothelioma: A study of 42 cases.
-
Autocrine growth stimulation by transforming growth factor alpha in asbestos-transformed rat mesothelial cells.
-
Bevacizumab-associated fistula formation in postoperative colorectal cancer patients.
-
CA 19-9 is an index of response to neoadjunctive chemoradiation therapy in pancreatic cancer.
-
Chemotherapy completion in elderly women with ovarian, primary peritoneal or fallopian tube cancer - An NRG oncology/Gynecologic Oncology Group study.
-
Cognitive function during and six months following chemotherapy for front-line treatment of ovarian, primary peritoneal or fallopian tube cancer: An NRG oncology/gynecologic oncology group study.
-
Colonic uptake of Tc-99m MDP in pseudomembranous colitis.
-
Colorectal Cancer Liver Metastases and Concurrent Extrahepatic Disease Treated With Resection.
-
Comparison of bevacizumab alone or with chemotherapy in recurrent ovarian cancer patients.
-
Consensus guidelines from The American Society of Peritoneal Surface Malignancies on standardizing the delivery of hyperthermic intraperitoneal chemotherapy (HIPEC) in colorectal cancer patients in the United States.
-
Crocidolite and mesothelioma.
-
Current treatment options and biology of peritoneal mesothelioma: meeting summary of the first NIH peritoneal mesothelioma conference.
-
Cytoreductive surgery and intraperitoneal chemotherapy for peritoneal carcinomatosis.
-
Desmoplastic small round cell tumor masquerading as advanced ovarian cancer.
-
Diagnoses and Difficulties in Mesenteric Pathology.
-
Diagnosis of posttransplant granulocytic sarcoma by fine-needle aspiration cytology and flow cytometry.
-
Effect of niraparib on cardiac repolarization in patients with platinum-sensitive, recurrent epithelial ovarian, fallopian tube, and primary peritoneal cancer.
-
Epidemiology of asbestos-related diseases.
-
Exposure to brake dust and malignant mesothelioma: a study of 10 cases with mineral fiber analyses.
-
Folate-targeted nanoparticle delivery of chemo- and radiotherapeutics for the treatment of ovarian cancer peritoneal metastasis.
-
Frontline Science: Microbiota reconstitution restores intestinal integrity after cisplatin therapy.
-
Gefitinib in patients with malignant mesothelioma: a phase II study by the Cancer and Leukemia Group B.
-
Gene expression profiling of peritoneal metastases from appendiceal and colon cancer demonstrates unique biologic signatures and predicts patient outcomes.
-
Generation of a syngeneic mouse model to study the effects of vascular endothelial growth factor in ovarian carcinoma.
-
Genome-wide association study evaluating single-nucleotide polymorphisms and outcomes in patients with advanced stage serous ovarian or primary peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study.
-
Germline polymorphisms in an enhancer of PSIP1 are associated with progression-free survival in epithelial ovarian cancer.
-
Guidelines for pathologic diagnosis of malignant mesothelioma: a consensus statement from the International Mesothelioma Interest Group.
-
Health-related quality of life outcomes of docetaxel/carboplatin combination therapy vs. sequential therapy with docetaxel then carboplatin in patients with relapsed, platinum-sensitive ovarian cancer: results from a randomized clinical trial.
-
Human Trial of a Genetically Modified Herpes Simplex Virus for Rapid Detection of Positive Peritoneal Cytology in the Staging of Pancreatic Cancer.
-
Identical-twin small-bowel transplant for desmoid tumour.
-
Imaging of pediatric mesenteric abnormalities.
-
Immature omental teratoma.
-
Impact of Peritoneal Metastasis on Survival of Patients With Small Intestinal Neuroendocrine Tumor.
-
Implications of peritoneal cytology for pancreatic cancer management.
-
In vivo reprogramming of hTERT by trans-splicing ribozyme to target tumor cells.
-
Intraductal papillary mucinous neoplasm (IPMN) with extra-pancreatic mucin: a case series and review of the literature.
-
Intraperitoneal chromic phosphate P 32 suspension therapy of malignant peritoneal cytology in endometrial carcinoma.
-
Irinotecan for malignant mesothelioma A phase II trial by the Cancer and Leukemia Group B.
-
Is Intraperitoneal Chemotherapy Dead?
-
Is port site resection necessary in the surgical management of gallbladder cancer?
-
Laparoscopy and mesothelioma.
-
Large mesenteric lymphangioma in an adult patient: an unusual presentation of a rare disease.
-
Localized malignant mesothelioma.
-
Lower frequency of peritoneal carcinomatosis in patients with pancreatic cancer diagnosed by EUS-guided FNA vs. percutaneous FNA.
-
Malignant Mesothelioma and Its Non-Asbestos Causes.
-
Malignant Peritoneal Mesothelioma Arising in Young Adults With Long-standing Indwelling Intra-abdominal Shunt Catheters.
-
Malignant mesothelioma and occupational exposure to asbestos: a clinicopathological correlation of 1445 cases.
-
Malignant mesothelioma in women.
-
Malignant mesothelioma not related to asbestos exposure: Analytical scanning electron microscopic analysis of 83 cases and comparison with 442 asbestos-related cases.
-
Malignant mesothelioma with heterologous elements: clinicopathological correlation of 27 cases and literature review.
-
Malignant peritoneal mesothelioma and Crohn disease.
-
Malignant peritoneal mesothelioma in patients with endometriosis.
-
Mesotheliomas induced in rats by the fibrous mineral erionite are independent from p53 alterations.
-
Metastatic melanoma of gastrocolic ligament treated with minimally invasive approach.
-
Mineral fiber content of lung tissue in patients with environmental exposures: household contacts vs. building occupants.
-
Modest advances in survival for patients with colorectal-associated peritoneal carcinomatosis in the era of modern chemotherapy.
-
Molecular Analysis of a Patient With Neurofibromatosis 2 (NF2) and Peritoneal Malignant Mesothelioma.
-
Morphologic correlates of molecular alterations in extrauterine Müllerian carcinomas.
-
Niraparib monotherapy for late-line treatment of ovarian cancer (QUADRA): a multicentre, open-label, single-arm, phase 2 trial.
-
Number, not size, of mesenteric tumor deposits affects prognosis of small intestinal well-differentiated neuroendocrine tumors.
-
Omental cakes in American Burkitt lymphoma. Computed tomography demonstration.
-
Ovarian teratoma with glial implants on the peritoneum. An analysis of 12 cases.
-
Pathologic distribution at the time of interval tumor reductive surgery informs personalized surgery for high-grade ovarian cancer.
-
Pathology of human mesothelioma. Etiologic and diagnostic considerations.
-
Patterns of failure after pancreaticoduodenectomy for ampullary carcinoma.
-
Pediatric radiology case of the day. Peritoneal carcinomatosis.
-
Percutaneous Peritoneal Lavage for the Rapid Staging of Gastric and Pancreatic Cancer.
-
Percutaneous Preoperative Biliary Drainage for Resectable Perihilar Cholangiocarcinoma: No Association with Survival and No Increase in Seeding Metastases.
-
Peritoneal carcinomatosis: preoperative CT with intraperitoneal contrast material.
-
Peritoneal fluid prolactin in infertile women with endometriosis: lack of evidence of secretory activity by endometrial implants.
-
Peritoneal lymphomatosis.
-
Phase I study of intraperitoneal recombinant human interleukin 12 in patients with Müllerian carcinoma, gastrointestinal primary malignancies, and mesothelioma.
-
Phase I trial of intraperitoneal iododeoxyuridine with and without intravenous high-dose folinic acid in the treatment of advanced malignancies primarily confined to the peritoneal cavity: flow cytometric and pharmacokinetic analysis.
-
Phase II trial of nintedanib in patients with bevacizumab-resistant recurrent epithelial ovarian, tubal, and peritoneal cancer.
-
Phase II trial of sunitinib in patients with metastatic colorectal cancer after failure of standard therapy.
-
Preoperative CA 19-9 and the yield of staging laparoscopy in patients with radiographically resectable pancreatic adenocarcinoma.
-
Primary peritoneal and ovarian cancers: an epidemiological comparative analysis.
-
Progesterone receptor activity in leiomyomatosis peritonealis disseminata.
-
Prognostic impact of RT-PCR-based detection of peritoneal micrometastases in patients with pancreatic cancer undergoing curative resection.
-
Prospective clinical trial of disulfiram plus copper in men with metastatic castration-resistant prostate cancer.
-
Pulmonary asbestos body counts and electron probe analysis of asbestos body cores in patients with mesothelioma: a study of 25 cases.
-
Pulmonary toxicity after intraperitoneal mitomycin C: a case report of a rare complication of HIPEC.
-
Randomized phase II trial of bevacizumab plus everolimus versus bevacizumab alone for recurrent or persistent ovarian, fallopian tube or peritoneal carcinoma: An NRG oncology/gynecologic oncology group study.
-
Randomized phase II trial of cisplatin with mitomycin or doxorubicin for malignant mesothelioma by the Cancer and Leukemia Group B.
-
Reduction of the intraperitoneal inflammation associated with endometriosis by treatment with medroxyprogesterone acetate.
-
Risk of occult irresectable disease at liver resection for hepatic colorectal cancer metastases: a contemporary analysis.
-
Rt-PCR increases detection of submicroscopic peritoneal metastases in gastric cancer and has prognostic significance.
-
Sarcomatoid Peritoneal Mesothelioma: Clinicopathologic Correlation of 13 Cases.
-
Sarcomatoid mesothelioma: a clinical-pathologic correlation of 326 cases.
-
Scavenger receptor-A-targeted leukocyte depletion inhibits peritoneal ovarian tumor progression.
-
Should mesenteric tumor deposits be included in staging of well-differentiated small intestine neuroendocrine tumors?
-
Surgical options for advanced/metastatic gastrointestinal stromal tumors.
-
Talc and mesothelioma: mineral fiber analysis of 65 cases with clinicopathological correlation.
-
Targeting Id1 and Id3 inhibits peritoneal metastasis of gastric cancer.
-
The Chicago Consensus on Peritoneal Surface Malignancies: Management of Appendiceal Neoplasms.
-
The Chicago Consensus on Peritoneal Surface Malignancies: Management of Colorectal Metastases.
-
The Chicago Consensus on Peritoneal Surface Malignancies: Management of Desmoplastic Small Round Cell Tumor, Breast, and Gastrointestinal Stromal Tumors.
-
The Chicago Consensus on Peritoneal Surface Malignancies: Management of Gastric Metastases.
-
The Chicago Consensus on Peritoneal Surface Malignancies: Management of Neuroendocrine Tumors.
-
The Chicago Consensus on Peritoneal Surface Malignancies: Management of Ovarian Neoplasms.
-
The Chicago Consensus on Peritoneal Surface Malignancies: Management of Peritoneal Mesothelioma.
-
The Chicago Consensus on Peritoneal Surface Malignancies: Palliative Care Considerations.
-
The Chicago Consensus on Peritoneal Surface Malignancies: Standards.
-
The Chicago Consensus on peritoneal surface malignancies: Management of appendiceal neoplasms.
-
The Chicago Consensus on peritoneal surface malignancies: Management of colorectal metastases.
-
The Chicago Consensus on peritoneal surface malignancies: Management of desmoplastic small round cell tumor, breast, and gastrointestinal stromal tumors.
-
The Chicago Consensus on peritoneal surface malignancies: Management of gastric metastases.
-
The Chicago Consensus on peritoneal surface malignancies: Management of neuroendocrine tumors.
-
The Chicago Consensus on peritoneal surface malignancies: Management of ovarian neoplasms.
-
The Chicago Consensus on peritoneal surface malignancies: Management of peritoneal mesothelioma.
-
The Chicago Consensus on peritoneal surface malignancies: Palliative care considerations.
-
The Chicago Consensus on peritoneal surface malignancies: Standards.
-
The Evolving Management of Peritoneal Surface Malignancies.
-
The activated transforming growth factor-beta signaling pathway in peritoneal metastases is a potential therapeutic target in ovarian cancer.
-
The addition of erlotinib to gemcitabine and cisplatin does not appear to improve median survival in metastatic pancreatic cancer.
-
The influence of positive peritoneal cytology on survival in patients with pancreatic adenocarcinoma.
-
The natural history of colorectal carcinoma in adolescents.
-
The role of analytical SEM in the determination of causation in malignant mesothelioma.
-
The separation of benign and malignant mesothelial proliferations.
-
Timing of end-of-life care discussion with performance on end-of-life quality indicators in ovarian cancer.
-
Transtubal spread of serous adenocarcinoma of the endometrium: an underrecognized mechanism of metastasis.
-
Treatment of primary colon cancer with peritoneal carcinomatosis: comparison of concomitant vs. delayed management.
-
Twenty-five years of fiber analysis: what have we learned?
-
Usefulness of sonographic guidance during percutaneous biopsy of mesenteric masses.
-
Weekly low-dose carboplatin and paclitaxel in the treatment of recurrent ovarian and peritoneal cancer.
-
Well-differentiated papillary mesothelioma.
-
Keywords of People
-
Berchuck, Andrew,
James M. Ingram Distinguished Professor of Gynecologic Oncology,
Obstetrics and Gynecology, Gynecologic Oncology
-
Dement, John McCray,
Professor Emeritus in Family Medicine and Community Health,
Family Medicine & Community Health,Occupational & Environmental Medicine
-
Jowell, Paul Simon,
Professor of Medicine,
Medicine, Gastroenterology
-
Moorman, Patricia Gripka,
Professor Emeritus in Family Medicine and Community Health,
Duke Cancer Institute
-
Pang, Herbert,
Adjunct Assistant Professor in the Department of Biostatistics & Bioinformatics,
Biostatistics & Bioinformatics
-
Stinnett, Sandra Sue,
Associate Professor of Biostatistics & Bioinformatics,
Biostatistics & Bioinformatics
-
Sullivan, Daniel Carl,
Professor Emeritus of Radiology,
Radiology